Onward Medical N.V. (ONWD.BR)

EUR 3.82

(-0.65%)

Operating Income Summary of Onward Medical N.V.

  • Onward Medical N.V.'s latest annual operating income in 2023 was -35.46 Million EUR , down -10.72% from previous year.
  • Onward Medical N.V.'s latest quarterly operating income in 2024 Q1 was -9.37 Million EUR , down -12.38% from previous quarter.
  • Onward Medical N.V. reported an annual operating income of -32.02 Million EUR in 2022, down -12.25% from previous year.
  • Onward Medical N.V. reported an annual operating income of -28.53 Million EUR in 2021, down -83.94% from previous year.
  • Onward Medical N.V. reported a quarterly operating income of -9.37 Million EUR for 2024 Q2, down 0.0% from previous quarter.
  • Onward Medical N.V. reported a quarterly operating income of -9.39 Million EUR for 2023 Q1, up 48.15% from previous quarter.

Annual Operating Income Chart of Onward Medical N.V. (2023 - 2018)

Historical Annual Operating Income of Onward Medical N.V. (2023 - 2018)

Year Operating Income Operating Income Growth
2023 -35.46 Million EUR -10.72%
2022 -32.02 Million EUR -12.25%
2021 -28.53 Million EUR -83.94%
2020 -15.51 Million EUR -44.0%
2019 -10.77 Million EUR -28.16%
2018 -8.4 Million EUR 0.0%

Peer Operating Income Comparison of Onward Medical N.V.

Name Operating Income Operating Income Difference
Nicox S.A. -17.5 Million EUR -102.611%
European Medical Solutions -135 Thousand EUR -26168.889%
FERMENTALG -11.8 Million EUR -200.33%
argenx SE -417.15 Million EUR 91.499%
BioSenic S.A. -7.04 Million EUR -403.736%
Celyad Oncology SA -8.45 Million EUR -319.333%
Hyloris Pharmaceuticals SA -15.99 Million EUR -121.741%
Oxurion NV -12.11 Million EUR -192.841%
PHAXIAM Therapeutics S.A. -23.66 Million EUR -49.886%
Financière de Tubize SA -2.14 Million EUR -1554.078%
UCB SA 604 Million EUR 105.871%